These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37025490)

  • 61. Treatment of primary biliary cirrhosis with ursodeoxycholic acid combined with traditional Chinese medicine: A protocol for systematic review and meta analysis.
    Chen X; Ma X; Wang R; Wang L; Li J; Liu H; He T; Wei S; Li H; Wang M; Zhao Y
    Medicine (Baltimore); 2020 Nov; 99(46):e23107. PubMed ID: 33181677
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chinese herbal medicines for unexplained recurrent miscarriage.
    Li L; Dou L; Leung PC; Chung TK; Wang CC
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD010568. PubMed ID: 26760986
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The clinical efficacy and adverse effects of Entecavir plus Thymosin alpha-1 combination therapy versus Entecavir Monotherapy in HBV-related cirrhosis: a systematic review and meta-analysis.
    Peng D; Xing HY; Li C; Wang XF; Hou M; Li B; Chen JH
    BMC Gastroenterol; 2020 Oct; 20(1):348. PubMed ID: 33076834
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Network Meta-analysis of efficacy and safety of Chinese patent medicines in treatment of ankylosing spondylitis].
    Fan JY; Chang C; Qin YY; Jiang T; He DY
    Zhongguo Zhong Yao Za Zhi; 2022 Apr; 47(8):2211-2227. PubMed ID: 35531738
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The efficacy and safety of Chinese herbal medicine, Rhodiola formulation in treating ischemic heart disease: a systematic review and meta-analysis of randomized controlled trials.
    Yu L; Qin Y; Wang Q; Zhang L; Liu Y; Wang T; Huang L; Wu L; Xiong H
    Complement Ther Med; 2014 Aug; 22(4):814-25. PubMed ID: 25146085
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study).
    Kong X; Kong Y; Zhang F; Wang T; Yan J
    Medicine (Baltimore); 2016 Oct; 95(40):e4949. PubMed ID: 27749550
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Long-term clinical impact and cost-effectiveness of obeticholic acid for the treatment of primary biliary cholangitis.
    Samur S; Klebanoff M; Banken R; Pratt DS; Chapman R; Ollendorf DA; Loos AM; Corey K; Hur C; Chhatwal J
    Hepatology; 2017 Mar; 65(3):920-928. PubMed ID: 27906472
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Network Meta-analysis of oral Chinese patent medicine for adjuvant treatment of primary liver cancer].
    Zhang RR; Shao MY; Fu Y; Zhao RX; Wang JW; Li M; Zhao YX; Shao FL
    Zhongguo Zhong Yao Za Zhi; 2021 May; 46(9):2333-2343. PubMed ID: 34047138
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Curative effects of traditional Chinese medicine on liver fibrosis: A protocol for a systematic review and meta-analysis.
    Gao X; Cao W
    Medicine (Baltimore); 2021 Mar; 100(9):e24587. PubMed ID: 33655924
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bezafibrate Improves GLOBE and UK-PBC Scores and Long-Term Outcomes in Patients With Primary Biliary Cholangitis.
    Honda A; Tanaka A; Kaneko T; Komori A; Abe M; Inao M; Namisaki T; Hashimoto N; Kawata K; Takahashi A; Ninomiya M; Kang JH; Arakawa M; Yamagiwa S; Joshita S; Umemura T; Sato K; Kaneko A; Kikuchi K; Itakura J; Nomura T; Kakisaka K; Fujii H; Kawada N; Takikawa Y; Masaki T; Ohira H; Mochida S; Yoshiji H; Iimuro S; Matsuzaki Y; Takikawa H;
    Hepatology; 2019 Dec; 70(6):2035-2046. PubMed ID: 30737815
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Network Meta-analysis of Chinese patent medicines in treatment of liver stagnation and spleen deficiency of depression].
    Yu Y; Zhang G; Han T; Li J; Huang HL
    Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(23):5217-5224. PubMed ID: 32237360
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Systematic review of randomized controlled trials of traditional Chinese medicine treatment of non-acute bronchial asthma complicated by gastroesophageal reflux.
    Zhao YH; Liu ZI; Li LH; Jiang SH; Shi CH
    J Tradit Chin Med; 2012 Mar; 32(1):12-8. PubMed ID: 22594096
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Network Meta-analysis of oral Chinese patent medicine in treatment of knee osteoarthritis].
    Zhao JL; Liang GH; Pan JK; Huang HT; Yang WY; Luo MH; Zeng LF; Li JH; Liu J
    Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):981-999. PubMed ID: 33645105
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficacy and Safety of
    Wang X; Wang H; Cao L; Wu J; Lu T; Li S; Li J
    Front Nutr; 2021; 8():784164. PubMed ID: 34957186
    [No Abstract]   [Full Text] [Related]  

  • 75. Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China.
    Zhuang W; Fan Z; Chu Y; Wang H; Yang Y; Wu L; Sun N; Sun G; Shen Y; Lin X; Guo G; Xi S
    Front Pharmacol; 2020; 11():1066. PubMed ID: 32848729
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Network Meta-analysis of efficacy and safety of Chinese patent medicines in treatment of insomnia].
    Shi ML; Zhao M; Wang YH; Sun TY; Li XL; Ren F; Bian SB; Cui ZH; Li SS
    Zhongguo Zhong Yao Za Zhi; 2021 Oct; 46(20):5403-5417. PubMed ID: 34738444
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Systematic review and meta-analysis of randomized controlled trials of Chinese herbal medicine in the treatment of Sjogren's syndrome].
    Luo H; Han M; Liu JP
    Zhong Xi Yi Jie He Xue Bao; 2011 Mar; 9(3):257-74. PubMed ID: 21419078
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCA.
    Hirschfield GM; Beuers U; Kupcinskas L; Ott P; Bergquist A; Färkkilä M; Manns MP; Parés A; Spengler U; Stiess M; Greinwald R; Pröls M; Wendum D; Drebber U; Poupon R
    J Hepatol; 2021 Feb; 74(2):321-329. PubMed ID: 32950590
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis.
    Corpechot C; Carrat F; Bonnand AM; Poupon RE; Poupon R
    Hepatology; 2000 Dec; 32(6):1196-9. PubMed ID: 11093724
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A randomized crossover trial to assess therapeutic efficacy and cost reduction of acid ursodeoxycholic manufactured by the university hospital for the treatment of primary biliary cholangitis.
    Nakano LA; Cançado ELR; Chaves CE; Madeira MCV; Katayose JT; Nabeshima MA; Fossaluza V; Uhrigshardt GG; Liting Z; Pinto VB; Carrilho FJ; Ono SK
    BMC Gastroenterol; 2020 Aug; 20(1):253. PubMed ID: 32758152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.